Ten select young scientists at UKE are to be funded as part of the iSTAR initiative. "Despite the increasing incidence of inflammatory diseases, there is as yet no drug therapy that addresses the causes and enables healing," said Prof. Dr. Samuel Huber, Director of the I. Medical Clinic at UKE. Inflammatory diseases are triggered in various organs by a misguided immune response from the immune system. Such reactions can eventually cause cancer.
Funding to support research-based specialists
The German Ministry of Education and Research is putting EUR 7.8 million towards the Integrative Advanced Clinician Scientists Targeting Inflammatory and Infectious Disease (iSTAR) programme at the University Hospital Hamburg-Eppendorf for clinically active young scientists. The funds should help put research results into practice swiftly and improve the care of people with such diseases.
Funding to enable research innovations
Support for young scientists
The funded scientists are so-called Advanced Clinician Scientists, i.e. researching physicians who have already completed their specialist training. The latest funds will ensure that the researchers can combine research and medical work as well as family and career over the next five years, according to UKE. An extensive mentoring programme is also being put in place. "We can now offer talented minds excellent support and career prospects based on our innovative concept," said Prof. Dr. Blanche Schwappach-Pignataro, Dean of the UKE Medical Faculty.
tn/sb/pb
Sources and further information
More
Similar articles
UKE co-ordinating new German paediatrics centre
Industry in Hamburg keen on coronavirus testing and vaccinations
Virtual nature can lift mood, study by University of Hamburg finds
